The role of the somatotropic axis in sleep regulation was studied by using the lit/lit mouse with non-functional growth hormone (GH)-releasing hormone (GHRH) receptors (GHRH-Rs) and control heterozygous C57BL/6J mice, which have a normal phenotype. During the light period, the lit/lit mice displayed significantly less spontaneous rapid eye movement sleep (REMS) and non-REMS (NREMS) than the controls. Intraperitoneal (ip) injection of GHRH (50 µg/kg) failed to promote sleep in the lit/lit mice whereas it enhanced NREMS in the heterozygous mice.
INTRODUCTION
Regulation of sleep and the somatotropic axis are intimately related. Deep non-rapid eye movement sleep (NREMS) is associated with growth hormone (GH) secretion (reviewed in 53).
The somatotropic axis hormones, GH-releasing hormone (GHRH), GH, insulin-like growth factor-1 (IGF-1), and somatostatin are capable of modulating sleep. The sleep-promoting activity of GHRH is documented in rats and rabbits (11, 36) and humans (21, 28, 45) . Independently from GHRH, GH may increase the intensity of NREMS (2) and the duration of rapid eye movement sleep (REMS) (10, 30, 46) . IGF-1 may promote NREMS (39) , and somatostatin may stimulate REMS (7) . In addition, acute rises in somatostatin, GH, and IGF-1 can suppress sleep via negative feed back inhibition of GHRH (reviewed in 40) . GHRH and the GHRH receptor (GHRH-R) genes are contained within the genomic regions implicated in homeostatic sleep regulation (12) and the sleep responses to viral influenza infection (52) in mice. Chronic hypoactivity of the somatotropic axis is associated with sleep alterations. Thus, REMS and the time spent in deep NREMS may decrease though total sleep time may increase in humans with decreased GH production (reviewed in 2). Transgenic mice with GHRH deficiency (TH-hGH mice) have decreased NREMS (57) . Spontaneous NREMS and REMS are lowered in the mutant dw/dw rat (37) which has a defect in GHRH-R signaling. In animals with decreased GHRH synthesis or a defect in GHRH-R signaling, however, the physiological stimulus of pituitary GH synthesis and release is absent, and concentrations of both GH and IGF-1 are low in the plasma resulting in a dwarf phenotype. Therefore, the significance of the individual hormones in the sleep deficit is difficult to clearly determine.
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The aim of the current experiments was to use the lit/lit mouse to study the role of GHRH in sleep regulation. The lit/lit mouse bears a point mutation in the GHRH-R gene resulting in a loss of receptor function (15, 25) , a model of genetic GHRH-R defects in humans (54) . By using the lit/lit mouse, we report that chronic GH infusion normalizes REMS whereas the NREMS deficiency persists in the chronic hypofunction of the somatotropic axis suggesting that these sleep alterations are linked to GH/IGF-1 and GHRH deficiencies, respectively. The lit/lit mice fail to exhibit sleep responses if given GHRH, the somatostatin analog, octreotide (OCT), or ghrelin, a hormone acting on the GH-secretagogue (GHS) receptor (GHS-R) (22) showing that these sleep responses are mediated via GHRH actions on GHRH-Rs.
METHODS

Animals.
Heterozygous male C57BL/6 (C57BL/6J-Ghrhr-lit-/+), and homozygous male lit/lit mice (n=56, each) were purchased from Jackson Laboratory, Bar Harbor, Maine. The mice were between 3 and 4 months of age at the time of the experiments. The heterozygous controls weighed 24.1 ± 0.69 g, the lit/lit mice weighed 11.4 ± 0.31 g (47.2 % of the body weight of the controls). The difference in body weight was significant between the two groups (Student t-test, p<0.0001). The animals were housed individually in Plexiglas® cages placed in environmental chambers on a 12-12 h light-dark cycle, at 30°C ambient temperature. Food and water were continuously available.
Surgery. The mice were anesthetized with ketamine-xylazine (87 and 13 mg/kg, respectively).
Stainless steel electrodes were placed on the top of the dura mater over the frontal and parietal lobes and the cerebellum. These electrodes were used to record the electroencephalogram (EEG).
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Two stainless steel wires were implanted into the dorsal neck muscles to record the electromyogram (EMG). The EEG and EMG electrodes were connected to a pedestal (0.4 g) implanted on the top of the skull. The surgeries were performed 7 days before recordings began.
Recording of sleep-wake activity. The mice were connected to light-weight recording cables and habituated to the experimental conditions during recovery. The cables were attached to commutators which were connected to amplifiers. The signals were digitized (128-Hz sampling rate) and collected by a computer and stored on compact discs. Power density spectra (0. 25-40.0 Hz in 0.5-Hz bands) were calculated on-line for consecutive 10-s EEG epochs and stored with the EEG and EMG signals. For scoring, the EEG and EMG signals and the power density spectra were restored on the computer screen. The states of vigilance were determined for 10-s epochs by the usual criteria as NREMS (high-amplitude EEG slow waves and low-tone muscle activity), REMS (highly regular theta EEG activity and loss of muscle tone with occasional twitches), and wakefulness (EEG activities similar to, but often less regular and with lower amplitude than, those in REMS and high EMG activity). The percentage of the time spent in each state of vigilance for 1-h periods was determined. The power values for the 0.5 to 4.0 Hz (delta) frequency range were integrated. The mean of these integrated values were calculated for uninterrupted periods of artifact-free NREMS, and used as an index of EEG slow wave activity (SWA) during NREMS to characterize sleep intensity (depth of sleep) in each recording hour.
When studying the peptide effects, sleep latency was also determined. Sleep latency was defined as the time prior to the first occurrence of 30-s continuous NREMS episode measured from the onset of the light period (after OCT administration) or dark period (after GHRH and ghrelin administration).
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Experimental schedule. Starting at light onset, the mice (n=26 heterozygous, and n=25 lit/lit mice) were recorded from for two consecutive days to obtain baseline values of spontaneous sleep-wake activity. On the third experimental day in 13 of the control and 13 of the lit/lit mice, sleep deprivation (SD) started at light onset and lasted for 4 hours. The EEG and EMG were recorded throughout SD, and during the remaining 8 h of the light period, and for 11 h during the subsequent dark cycle (collected data were backed up sometime during the last hour of the dark period and the records in this hour were discarded). SD was performed by gentle handling while the mice stayed in their home cage; whenever behavioral or EEG signs of sleep were observed, the mice were aroused by knocking on the cage or lightly touching them. It is assumed that stress is not a major factor determining the sleep response to SD, at least when SD is performed by gentle handling (18) , though sleep loss itself may represent a stressor and may alter hypothalamo-pituitary-adrenal functions (29) .
The mice, which were used in the GH replacement experiment, were subcutaneously implanted with osmotic mini-pumps (ALZET 1002, 0.25 µl/h for 14 days; Durect Corporation, Cupertino, CA) in the back (weight after loading: 0.5 g). The minipumps were filled with mouse GH (mGH) and approximately half of the groups were injected with the vehicle and half of the groups with the peptide on the first day. Some of the mice tested with GHRH were previously used in the SD experiments. In this case, one week elapsed between these experiments. Some mice were tested with both ghrelin and OCT; there was at least one day off between these tests.
Ghrelin-induced GH secretion.
The effects of an ip injection of 400 µg/kg ghrelin on plasma GH concentration was studied in 7 lit/lit and 8 heterozygous mice. To obtain control values, physiological saline was injected to 10 lit/lit and 10 heterozygous mice. The mice were decapitated 15 min after injections and the trunk blood was collected. The blood was centrifuged and the plasma was stored at -20 °C until the radioimmunoassay. The immunoreagents for determining plasma GH were provided by NHPP-NIDDK. GH was measured in duplicate, the intra-assay coefficient of variation was less than 7 %. 
Effects of GH infusion on plasma
Determination of the point mutation in intracerebral GHRH-R.
The hypothalamus plus preoptic region (landmarks: frontal edge of the optic chiasma, lateral sulci, mammillary bodies, and a depth of 1 mm) and the pituitary gland were harvested from two lit/lit mice and two heterozygous mice. Total RNA was isolated from hypothalamus and pituitary using GibcoBRL's TRIzol reagent. The RNA was then subsequently DNase-treated with
RNase-free DNAse from Ambion (Austin, TX). Using a high fidelity enzyme in the TITAN one-tube RT-PCR system from Boehringer Mannheim (Germany). GHRH-R mRNA was amplified from 1 µg RNA; the primers used were sense 5' (cggcagaggggaccaacaacac) and antisense 5' (cacagggcaagccacagggtatg).
The RT-PCR product was electrophoresed on a 1% agarose ethidium bromide gel, and purified by MinElute Gel Extraction kit from Qiagen (Valencia, CA). Gel isolated DNA was then subsequently amplified for nucleotide sequencing by the Department of Biochemistry from Washington State University.
Statistics. The results are provided as mean values ± SE. Sleep parameters on the two baseline days or the two days after GH infusion were averaged for each mouse. Two-way ANOVA was used to compare hourly values of NREMS, REMS and SWA among the various groups, and between baseline and experimental day in one group. Group effects (independent samples; e.g. These experiments are consistent with the guiding principles for research on animals issued by the American Physiological Society (1).
RESULTS
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Mutation of hypothalamic GHRH-R
The nucleotide sequence of the hypothalamic GHRH-R obtained from the lit/lit mice differed by one base (a guanine was substituted for an adenine) thereby leading to an altered codon 60 changing from aspartic acid to glycine in the lit/lit mice. These results confirm those previously reported for the pituitary GHRH-R in the lit/lit mice (15) .
Spontaneous sleep
The control heterozygous mice and the lit/lit mice exhibited a normal diurnal rhythm of sleep with more NREMS and REMS during the light period than at night (Fig. 1 whereas the duration of the REMS episodes was normal in lit/lit mice (1.5 ± 0.02 min and 1.5 ± 0.04 min in the heterozygous and lit/lit mice, respectively). REMS was not altered at night.
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The EEG SWA during NREMS in both mouse strains was relatively high after light onset, declined during the day and rose during the dark period. The interindividual variability in EEG SWA was high and significant differences between the heterozygous and lit/lit mice could not be detected. The nocturnal rise in EEG SWA tended to be smaller in the lit/lit mice than in the controls because the mean NREMS-associated power in the delta frequency range was significantly higher at night than during the day in the heterozygous mice (Wilcoxon-test, 
Effects of GH Replacement
After 1 week of GH infusion, the weight gain of the lit/lit mice (+1.9 ± 0.22 g) was significantly
higher than the weight gain of heterozygous mice infused with physiological saline (+0.8 ± 0.23, Student t-test, p<0.005). The weight gain may depend on GH dose for it was +2.11 ± 0.22 g in the mice infused with 24 µg rGH/day in contrast with the weight gain of +1.0 ± 0.47 g in the ng/ml) after one week of infusion of 24 µg rGH/day, indicating that the treatment was effective though IGF-1 concentration remained below normal.
Irrespective of the GH dose, GH infusion failed to alter NREMS in the lit/lit mice (Fig. 1) . In contrast, REMS increased in the lit/lit mice receiving chronic GH administration. The REMS response to GH was only slightly stronger after the larger GH dose than after the smaller dose (+13 ± 3.2 min vs. +11 ± 3.4 min in the 12-h light period), and the sample size did not allow statistical comparisons between the doses. In Fig. 1 and in the statistics, the mice infused with the low and high GH doses were pooled. When comparing the duration of REMS in the lit/lit mice before and after GH treatment, the increases in REMS were significant during the light period [F(1,11)=23.12, p<0.001]. After GH infusion, the statistical difference in REMS between the heterozygous mice and the lit/lit mice disappeared. REMS in lit/lit mice at night was not altered by GH administration.
After GH infusion, the nocturnal rise in EEG SWA during NREMS became significant (Wilcoxon test, p<0.001). The ratio of delta power to total power during NREMS was the same
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as in the heterozygous mice, i.e. slightly higher than in the lit/lit mice without GH infusion. The other power parameters, including the power in the various EEG frequency ranges, did not differ from values in the heterozygous or lit/lit mice without GH infusion.
Sleep deprivation
The increases in the time spent in NREMS were small after SD; the most obvious change occurred in hour 2 after SD in both groups of mice (Fig. 2) . In control mice, however, small increases in NREMS occurred for 6 hours, and the changes were significant calculated for the 8 The time spent in REMS increased during the last hours of the light period after SD in both groups of mice (Fig. 2) In heterozygous mice, a prominent EEG SWA response was elicited by SD (Fig. 2) ; EEG SWA during NREMS was about 50% higher in hour 1 after SD. SD-enhanced EEG SWA declined 
Effects of OCT
The amount of NREMS was between 30-40 % recording time in undisturbed mice during the first hour of the light period ( Figs. 1 and 2) . As indicated by the low amount of sleep in hour 1 the ip injection of the vehicle at light onset was a stressful for the mice in both groups (Fig. 3) . In the heterozygous mice, injection of OCT significantly delayed sleep onset (32.1 ± 2.5 min after vehicle, and 52.2 ± 3.9 min after OCT, paired t-test, p<0.001), and decreased the time spent in NREMS in hour 1 (paired t-test, p<0.05). In the OCT-treated control mice, NREMS time returned to normal in hour 2. EEG SWA during NREMS increased significantly in hour 2, remained high in hours 3 and 4, then returned to baseline in hour 5 (not shown). These µg/kg OCT whereas drinking never occurred after injection of the vehicle.
Effects of GHRH
GHRH enhanced NREMS in the heterozygous mice (Fig. 3) . 
Effects of ghrelin
The mean plasma GH concentrations were 20.5 ± 5.71 ng/ml and 7.21 ± 1.1 ng/ml in heterozygous and lit/lit mice, respectively, 15 min after ip injection of physiological saline. The difference between the two groups was statistically significant (Mann-Whitney test, p<0.05). In response to ip injection of 400 µg/kg ghrelin, the GH concentration in the plasma exceeded 128 ng/ml, the top value of the calibration curve, in every control mouse. In the lit/lit mice, after ghrelin injection, the plasma GH concentration was 8.13 ± 2.92 ng/ml, and this value did not differ from the baseline value in these mice.
In the heterozygous mice, ghrelin induced a significant decrease in sleep latency (45.0 ± 6.3 min after saline and 17.2 ± 2.2 min after ghrelin, paired t-test, p<0.001), and a significant increase in NREMS in hour 1 (paired t-test, P<0.05) (Fig. 3) . Sleep time, however, returned to baseline thereafter, and the changes in NREMS were not significant when calculated for 4 hours. REMS and EEG SWA were not altered after injection of ghrelin (not shown). In the lit/lit mice, ghrelin had no effect on sleep latency (43.2 ± 13.7 min after saline, and 39.8 ± 9.1 min after ghrelin), duration of NREMS or REMS, or EEG SWA. Bouts of eating were noted in each control mouse and in all but one lit/lit mouse during the initial 10 min after the injection of ghrelin.
DISCUSSION
The experiments were designed with the anticipation that studies on the lit/lit mice would promote our understanding of the role of the somatotropic axis hormones in sleep regulation. The reduction in spontaneous NREMS in the lit/lit mice as reported here is also characteristic of the TH-hGH transgenic mice which have decreased GHRH production (57), and of dwarf (dw/dw) rats which have a defect in GHRH receptor signaling (37) . One novelty of the current study is that GH replacement for 8-9 days restores REMS whereas it fails to increase NREMS time in the There is a great variability among mice strains in the effects of SD on NREMS duration (12, 18) .
Calculated in percent recording time, small, 3.6 %, increases in NREMS time were reported during 6 h recovery after 4-h SD in C57BL/6J mice and these changes did not reach the level of statistical significance (18) . The increment in NREMS time was in fact small albeit consistent across several hours in both the light and the dark periods in the heterozygous mice. Apart from a brief enhancement in NREMS in hour 2 after SD, this response did not occur in the lit/lit mice.
In contrast, both control and lit/lit mice exhibited enhanced EEG SWA after SD. This is unexpected because the SD-induced enhancements in EEG SWA are greatly attenuated in the dw/dw rats (37) . In mice, a 4-h SD is suggested to elicit maximal EEG SWA responses (18) , and perhaps this amount of SD is not suitable for the demonstration of small differences in responsiveness.
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The deficit in GHRH signaling itself is the likely candidate for the decreases in spontaneous NREMS and for the reduced NREMS response to SD in the lit/lit mice. In fact, the NREMSpromoting activity of GHRH does not require GH (38) ; instead, this GHRH action is mediated by the hypothalamus / preoptic region (58) . These observations imply that GHRH-Rs are expressed by neurons in the hypothalamus, and that these receptors are affected by the genetic mutation in the lit/lit mouse. The presence of GHRH-R mRNA was previously described in the rat hypothalamus (47) . Current results show that GHRH-R mRNA is also expressed in the hypothalamus / preoptic region of the mouse. The reported point mutation in pituitary GHRH-R (15, 25) was demonstrated in the hypothalamic GHRH-R suggesting that central GHRHergic activity is abolished the same way as GHRH actions in the pituitary.
That the NREMS-promoting activity is a specific effect of GHRH on GHRH-Rs is demonstrated by the failure of lit/lit mice to respond to GHRH. To our knowledge, the current report is the first description of the effects of GHRH on sleep in mice. GHRH strongly increased the duration of NREMS but, in contrast to the findings in previously studied species, it failed to increase EEG SWA during NREMS in heterozygous mice. However, the sleep response to an ip injection of GHRH at the onset of the active period in the mouse might not be comparable to the effects of systemically injected GHRH during the rest period in humans and rats, or to intracerebral administration of GHRH during the active period to the rat (reviewed in 40). reported decreases in REMS in the 9 h observation period during which ghrelin pulses were delivered. Alterations in REMS did not occur in our experiments but the mice were recorded at night when spontaneous REMS time was already low. Although our results provide evidence for the NREMS-promoting capacity of ghrelin the efficacy of ghrelin and GHRH cannot be compared without determining dose-response relationships for both peptides. In the lit/lit mice,
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ghrelin failed to stimulate NREMS and GH secretion while it continued to elicit feeding. This suggests, therefore, that GHRH might be involved in the mediation of the sleep-promoting activity of ghrelin but not in ghrelin-induced feeding. In fact, feeding is attributed to ghrelininduced stimulation of neuropeptide Y-containing neurons in the arcuate nucleus (9, 43) .
OCT elicits prompt suppression of GH secretion in rats (4). This effect is mediated in part via sst2 somatostatin receptors expressed by the pituitary somatotroph cells (42) , and in part via sst2
receptors inhibiting GHRHergic neurons in the hypothalamus (24, 59) . OCT also elicits immediate inhibition of sleep followed by enhancements in EEG SWA during NREMS starting in hours 2 to 3 postinjection (4,16). The changes in GH secretion and sleep after OCT correlate in time with the variations in hypothalamic GHRH contents elicited by OCT (14) . Although GHRH might be involved in the sleep response to OCT, somatostatin is a ubiquitous neurotransmitter in the CNS, and OCT may elicit a number of effects which inhibit sleep without directly interfering with GHRH. In fact, OCT induces drinking, vasopressin secretion and rises in blood pressure, which are attributed to a stimulation of intrahypothalamic angiotensin II release (17) . Experiments in the lit/lit mouse demonstrate that the sleep response to OCT is absent in these mice with non-functional GHRH-Rs whereas OCT-induced drinking seems to persist.
These results suggest that functional GHRH-Rs are necessary for the sleep effects of OCT, and that the OCT-induced angiotensinergic activity might not be dependent on GHRH action. That the sleep response to OCT is independent of angiotensin was previously reported; inhibition of angiotensin blocks the effects of OCT on drinking while not interfering with the sleep responses (4).
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In conclusion, the results from the lit/lit mice suggest that the decrease in REMS is linked to GH deficiency, and that somatostatin and ghrelin may modulate NREMS via GHRH. The NREMS deficit in the lit/lit mice is consistent with the proposed importance of GHRH in the regulation of NREMS though other factors may also contribute to this alteration. were studied during the dark period (injection at dark onset). Asterisks denote significant
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